Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures.
Topiramate tablets are also indicated as an adjunctive therapy for adults and pediatric patients aged two to 16 with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients two years of age or older with seizures associated with Lennox-Gastaut syndrome. Topiramate tablets are the generic version of Ortho-McNeil-Janssen’s Topamax tablets.